[go: up one dir, main page]

MX2007002291A - Composicion antimicrobiana administrable oralmente. - Google Patents

Composicion antimicrobiana administrable oralmente.

Info

Publication number
MX2007002291A
MX2007002291A MX2007002291A MX2007002291A MX2007002291A MX 2007002291 A MX2007002291 A MX 2007002291A MX 2007002291 A MX2007002291 A MX 2007002291A MX 2007002291 A MX2007002291 A MX 2007002291A MX 2007002291 A MX2007002291 A MX 2007002291A
Authority
MX
Mexico
Prior art keywords
antimicrobial composition
composition
lactulose
perorally administrable
antibiotic
Prior art date
Application number
MX2007002291A
Other languages
English (en)
Inventor
Dmitry Sergeevich Chicherin
Original Assignee
Kiselev Nikolai Alexandovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36000449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007002291(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kiselev Nikolai Alexandovich filed Critical Kiselev Nikolai Alexandovich
Publication of MX2007002291A publication Critical patent/MX2007002291A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere a medicina y a la industria quimica y farmaceutica, en particular a formas de preparacion de antibioticos. La composicion antimicrobiana de la invencion contiene antibioticos seleccionados del grupo de: lincosamidas, penicilinas de amplio espectro, cefalosporinas, macrolidas, tetraciclinas, y lactulosa, como componentes activos, en una proporcion de 1:1 a 1:100. El tamano medio de particula de la lactulosa varia de 100 nm a 200 mum.
MX2007002291A 2004-08-30 2005-08-25 Composicion antimicrobiana administrable oralmente. MX2007002291A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2004126203/15A RU2284832C2 (ru) 2004-08-30 2004-08-30 Антимикробная композиция для перорального введения
PCT/RU2005/000434 WO2006025767A2 (fr) 2004-08-30 2005-08-25 Composition antimicrobienne destinee a une administration perorale

Publications (1)

Publication Number Publication Date
MX2007002291A true MX2007002291A (es) 2008-02-12

Family

ID=36000449

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002291A MX2007002291A (es) 2004-08-30 2005-08-25 Composicion antimicrobiana administrable oralmente.

Country Status (21)

Country Link
US (1) US8231871B2 (es)
EP (1) EP1790357B1 (es)
JP (1) JP5062480B2 (es)
CN (1) CN101031321B (es)
AT (1) ATE410185T1 (es)
AU (1) AU2005280704B2 (es)
BR (1) BRPI0514708A (es)
CA (1) CA2620919C (es)
DE (1) DE602005010280D1 (es)
DK (1) DK1790357T3 (es)
EA (1) EA010199B1 (es)
ES (1) ES2314708T3 (es)
MX (1) MX2007002291A (es)
NZ (1) NZ554212A (es)
PL (1) PL1790357T3 (es)
PT (1) PT1790357E (es)
RU (1) RU2284832C2 (es)
TR (1) TR200703565T1 (es)
UA (1) UA85608C2 (es)
WO (1) WO2006025767A2 (es)
ZA (1) ZA200704449B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7485319B2 (en) 2003-07-25 2009-02-03 Warner Chilcott Company, Inc. Doxycycline metal complex in a solid dosage form
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
RU2325187C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и пребиотиков (варианты) для профилактики и лечения дисбиозов в процессе антибактериальной терапии
RU2325166C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и лактулозы для профилактики энтеральных дисбиозов в процессе антибиотикотерапии
HRP20150811T1 (hr) * 2008-03-18 2015-09-11 Dikovskiy, Aleksander Vladimirovich Farmaceutski pripravak za spreäśavanje disbioze povezane s enteralnom primjenom antibiotika
US20110033526A1 (en) * 2008-03-18 2011-02-10 Aleksander Vladimirovich Dikovskiy Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy
RU2415684C2 (ru) * 2008-04-16 2011-04-10 Александр Владимирович Диковский Фармацевтическая композиция для лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц и способ лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц
AU2014262710B2 (en) 2013-05-07 2019-09-12 Revvity Health Sciences, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582068A (en) * 1977-12-09 1980-12-31 Morinaga Milk Industry Co Ltd Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder
IL75800A (en) * 1984-07-23 1988-11-30 Lilly Co Eli Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
JPH0614862B2 (ja) * 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JPS6483025A (en) * 1987-09-24 1989-03-28 Fujio Hayashi Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
IE68841B1 (en) * 1988-03-18 1996-07-10 Duphar Int Res Method of preparing solid lactulose
FI87880C (fi) * 1990-06-27 1993-03-10 Valio Meijerien Foder som befraemjar tillvaexten och tarmfunktionen hos djur
KR100388569B1 (ko) * 1994-04-22 2003-10-11 야마노우치세이야쿠 가부시키가이샤 결장특이적약물방출용경구약제학적제제
JP2000516222A (ja) * 1996-08-15 2000-12-05 ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング 嚥下が容易な経口医薬組成物
JPH10194975A (ja) * 1997-01-10 1998-07-28 Morinaga Milk Ind Co Ltd 肝疾患治療剤
IT1297538B1 (it) * 1997-08-01 1999-12-17 Francesco Vicidomini Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
RU2131260C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Препарат для лечения желудочно-кишечных заболеваний
DE60004793T2 (de) * 1999-03-03 2004-07-01 Eli Lilly And Co., Indianapolis Echinocandin-kohlenhydrate-komplexe
ATE314091T1 (de) * 1999-06-09 2006-01-15 Mochida Pharm Co Ltd System für wirkstofffreisetzung im unteren verdauungstrakt

Also Published As

Publication number Publication date
BRPI0514708A (pt) 2008-06-24
DE602005010280D1 (de) 2008-11-20
TR200703565T1 (tr) 2007-08-21
NZ554212A (en) 2009-08-28
EP1790357B1 (en) 2008-10-08
ZA200704449B (en) 2008-08-27
UA85608C2 (ru) 2009-02-10
DK1790357T3 (da) 2009-02-02
ES2314708T3 (es) 2009-03-16
WO2006025767A3 (fr) 2006-08-17
US8231871B2 (en) 2012-07-31
CN101031321B (zh) 2010-12-15
CA2620919A1 (en) 2006-03-09
JP2008511622A (ja) 2008-04-17
CA2620919C (en) 2014-10-14
EA200700357A1 (ru) 2008-06-30
PL1790357T3 (pl) 2009-03-31
AU2005280704B2 (en) 2010-10-07
EA010199B1 (ru) 2008-06-30
WO2006025767A8 (en) 2007-04-05
ATE410185T1 (de) 2008-10-15
US20070254023A1 (en) 2007-11-01
WO2006025767A2 (fr) 2006-03-09
CN101031321A (zh) 2007-09-05
EP1790357A2 (en) 2007-05-30
RU2284832C2 (ru) 2006-10-10
RU2004126203A (ru) 2006-02-10
AU2005280704A1 (en) 2006-03-09
JP5062480B2 (ja) 2012-10-31
EP1790357A4 (en) 2007-11-07
PT1790357E (pt) 2008-12-31

Similar Documents

Publication Publication Date Title
ZA200704449B (en) Perorally administrable antimicrobial composition
JP2005524658A5 (es)
CA2115381A1 (en) Rifaximin and Pharmaceutical Compositions Containing It in the Treatment of Gastric Dyspepsia Caused by Helicobacter Pylori
BR0008059A (pt) Composições de valdecoxib
WO2004093795A3 (en) Compositions for delivery of drug combinations
EP2263675A3 (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
WO2004087043A3 (en) Stable ophthalmic formulation containing an antibiotic and a corticosteroid
WO2003028696A3 (en) Compositions for delivery of drug combinations
WO2005041934A3 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
WO2008039406A3 (en) Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
WO2008006534A3 (en) Multiple unit tablets
WO2006021160A8 (fr) Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système
WO2007116102A3 (en) Therapeutic composition and use
WO2000054780A3 (en) Corticosteroid formulation
WO2007075794A3 (en) Oral formulations comprising tigecycline
BG103958A (en) Pharmaceutical compositions of thioxanide and nitazoxanide
WO2003066022A3 (en) Stable pharmaceutical composition useful for treating gastrointestinal disorders
WO2005009407A3 (en) Oral pharmaceutical formulations of olanzapine
WO2003075852A3 (en) Antibiotic composition
WO2002096354A3 (en) Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
WO2003039437A3 (de) Oral verabreichbare pharmazeutische zubereitung umfassend liposo mal verkapseltes taxol
WO2005065685A8 (en) Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
WO2007119249A3 (en) Pharmaceutical compositions of cefixime
WO2008009589A3 (en) Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
MX2021012320A (es) Composiciones farmaceuticas solidas para el tratamiento del hcv.

Legal Events

Date Code Title Description
FG Grant or registration